Dr. Catherine Armstrong
Chief Scientific Officer
Replay available
USANA Health Sciences, Inc. (NYSE: USNA) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

Chief Scientific Officer
Analyst, Tigris Financial Partners
Director of Investor Relations
Analyst, Sidoti & Company
Chairman and Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Chief Operating Officer
Greetings and welcome to the USANA Health Sciences second quarter 2026 earnings. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I'd now like to turn the conference over to your host, Andrew Masuda, Director of Investor Relations. Please go ahead. Thank you and good morning everyone. We appreciate you joining us to review our second quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.isana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2026, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with Disclosures including specific risk factors and financial data contained in our most recent filings with the SEC. I'm joined by our Chairman and Chief Executive Officer, Kevin Guest, our Chief Financial Officer, Doug Hekking, our Chief Commercial Officer, Brent Neidig, our Chief Operating Officer, Walter Noot, our Chief Scientific Officer, Dr. Ca...